Sign inGet started

Ryali Sriram

Insider CIK 1762893 · CDXS Chief Financial Officer · EIGR Chief Financial Officer · CRBU Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRBU Caribou Biosciences, Inc. A Award deriv2026-02-202026-02-20247,500— $0247,500SEC↗
CRBU Caribou Biosciences, Inc. A Award2026-02-202026-02-2055,000— $072,360SEC↗
CRBU Caribou Biosciences, Inc. P Buy2025-01-292025-01-3017,360$1.42 $24.7K17,360SEC↗
CRBU Caribou Biosciences, Inc. A Award deriv2025-01-102025-01-10300,000— $0300,000SEC↗
CDXS CODEXIS, INC. A Award deriv2024-01-012024-01-02314,125— $0314,125SEC↗
CDXS CODEXIS, INC. A Award2024-01-012024-01-0252,350— $0175,791SEC↗
CDXS CODEXIS, INC. P Buy2023-09-082023-09-1211,650$1.70 $19.8K123,441SEC↗
CDXS CODEXIS, INC. A Award deriv2023-02-102023-02-14372,637— $0372,637SEC↗
CDXS CODEXIS, INC. A Award2023-02-102023-02-14111,791— $0111,791SEC↗
EIGR Eiger BioPharmaceuticals, S Sale2022-03-142022-03-142,266$5.60 $12.7K41,566SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2022-03-112022-03-11143,000— $0143,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2022-03-112022-03-1124,000— $043,832SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2021-07-292021-07-3030,000— $030,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2021-05-102021-05-1187,000— $087,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2021-03-122021-03-1597,500— $097,500SEC↗
EIGR Eiger BioPharmaceuticals, A Award2021-03-122021-03-1516,250— $018,152SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2020-03-122020-03-1365,000— $065,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2020-03-052020-03-13229$7.31 $1.7K1,628SEC↗
EIGR Eiger BioPharmaceuticals, A Award2019-09-052019-09-06149$9.37 $1.4K1,399SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2019-04-222019-04-221,250$11.08 $13.8K1,250SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2019-01-032019-01-0490,000— $090,000SEC↗